Securities – Fraud – Scienter : vimarsana.com
Securities – Fraud – Scienter
Where a securities fraud complaint has been filed over the failed commercial rollout of an innovative treatment for Alzheimer’s disease, the complaint must be dismissed because (1) none of the defendants’ 25 allegedly false and misleading statements are actionable under the Private Securities Litigation Reform Act and (2) the facts alleged do not support a
Related Keywords
Oklahoma, United States, Alfred Sandrock, Janet Woodcock, Michel Vounatsos, Alisha Alaimo, Veterans Health Administration, Defendants Biogen Inc, Drug Administration, Private Securities Litigation Reform Act, Plaintiff Oklahoma Firefighters Pension, Retirement System, Oklahoma Firefighters, Defendants Biogen, Chief Executive Officer, Chief Medical, Oklahoma Firefighter, Securities,